Respiratory diseases are leading causes of death and disability in the world.

    About 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year.

    BrOxy M is a medical device, wearable on the patient’s wrist. It's suitable principally to diagnose and monitor patients with chronic cardiac and respiratory failure.

    COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Life Meter is committed to implement the BrOxy technology in order support the fight against COVID-19.


    BrOxy M is a non-invasive and wearable medical device  it offers an innovative support to clinicians and healthcare professionals in:

    early diagnosis of diseases

    empowering diagnostic procedures

    improvement in management  and monitoring  of cardio-respiratory patients 

    LIFE METER SRL attraverso il progetto BrOxy è tra i beneficiari dei finanziamenti del
    PON “Imprese e Competitività” 2014-2020 – ASSE III Priorità di investimento 3 Azione 3.5.1.